| Cases | Controls | OR (95% CI) | OR (95% CI)* |
---|---|---|---|---|
All women | (n = 228) | (n = 226) | Â | Â |
Allele frequencies | Â | Â | Â | Â |
CYP1B1(Val) | 0.86 | 0.89 | Â | Â |
CYP1B1(Leu) | 0.14 | 0.11 | Â | Â |
Genotype frequencies | Â | Â | Â | Â |
CYP1B1 (Val/Val) | 167 (47.85) | 182 (52.15) | 1.00 | Â |
CYP1B1 (Val/Leu) | 57 (59.38) | 39 (40.62) | 1.59 (1.01–2.52) | 1.57 (0.99–2.51) |
CYP1B1 (Leu/Leu) | 4 (44.44) | 5 (55.6) | 0.87 (0.23–3.30) | 0.94 (0.24–3.64) |
CYP1B1 (Val/Val) | 167 (47.85) | 182 (52.15) | 1.00 | Â |
CYP1B1 (Val/Leu) + (Leu/Leu) | 61 (58.10) | 44 (41.90) | 1.51 (0.92–2.35) | 1.51 (0.96–2.36) |
Pre-menopausal women | (n = 125) | (n = 129) | Â | Â |
Allele frequencies | Â | Â | Â | Â |
CYP1B1(Val) | 0.85 | 0.92 | Â | Â |
CYP1B1(Leu) | 0.15 | 0.08 | Â | Â |
Genotype frequencies | Â | Â | Â | Â |
CYP1B1 (Val/Val) | 91 (45.50) | 109 (54.50) | 1.00 | Â |
CYP1B1 (Val/Leu) | 30 (62.50) | 18 (37.50) | 2.00 (1.05–3.81) | 1.97 (1.02–3.81) |
CYP1B1 (Leu/Leu) | 4 (66.67) | 2 (33.33) | 2.40 (0.43–13.38) | 2.64 (0.46–15.23) |
CYP1B1 (Val/Val) | 91 (45.50) | 109 (54.50) | 1.00 | Â |
CYP1B1 (Val/Leu) + (Leu/Leu) | 34 (62.96) | 20 (37.04) | 2.04 (1.10–3.78) | 2.04 (1.07–3.81) |
Postmenopausal women | (n = 103) | (n = 97) | Â | Â |
Allele frequencies | Â | Â | Â | Â |
CYP1B1(Val) | 0.87 | 0.86 | Â | Â |
CYP1B1(Leu) | 0.13 | 0.14 | Â | Â |
Genotype frequencies | Â | Â | Â | Â |
CYP1B1 (Val/Val) | 76 (51.00) | 73 (49.00) | 1.00 | Â |
CYP1B1 (Val/Leu) | 27 (56.30) | 21 (43.80) | 1.24 (0.64–2.38) | 1.20 (0.62–2.34) |
CYP1B1 (Leu/Leu) | 0 (0.00) | 3 (100.00) | ** | ** |
CYP1B1 (Val/Val) | 76 (51.00) | 73 (49.00) | 1.00 | Â |
CYP1B1 (Val/Leu) + (Leu/Leu) | 27 (52.94) | 24 (47.06) | 1.08 (0.57–2.04) | 1.05 (0.55–2.01) |